Home 2017
Archives
AACR: Five-Year Survival 16 Percent With Nivolumab in NSCLC
Of the 16 patients who survived at least five years, nine were male, 12 were current smokers at baseline
AACR: Regular Aspirin Use Linked to Lower Cancer Mortality
Regular aspirin use linked to lower risk of dying from cancer, especially colorectal, breast, prostate cancer
AACR: Atezolizumab Aids Some With Triple-Negative Breast CA
A minority of women with triple-negative tumors responded to atezolizumab, but they responded well
Obstructive Sleep Apnea May Increase Nighttime Urination
Researchers find nocturia reduced when CPAP is used
Nocturia May Be Reduced by Cutting Daily Intake of Salt
An easy way for patients to reduce nighttime urination and subsequent impact on sleep
Oxybutynin Frequently Used for Overactive Bladder in U.S. Elderly
Despite known adverse effects, including cognitive decline, oxybutynin most frequently prescribed
MRI-Based Strategy Reduces Biopsies in Prostate CA Screening
MRI-based screening could reduce unnecessary biopsies, overdiagnosis of low-grade cancer
Early, Goal-Directed Therapy No Benefit in Septic Shock
Patient-level meta-analysis shows similar mortality at 90 days for EGDT and usual care
DEX Doesn’t Reduce Mortality in Those With Sepsis on Ventilator
Dexmedetomidine also did not reduce ventilator-free days for sepsis patients on mechanical ventilation
No Hemodynamic Benefit With Levosimendan After Cardiac Sx
No decrease in 30-day mortality for patients undergoing hemodynamic support after cardiac sx
